If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Digital Technology » Digital Technology and Innovation
Download FREE Excerpt
10 Info Graphics
17 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
As Digital Marketing strategies and tactics evolve, companies are adjusting their digital marketing approaches to reach customers not only during launch but throughout the product lifecycle as well. Likewise, pharmaceutical organizations are continually fine-tuning their staffing for Digital Marketing teams to reflect marketplace and lifecycle needs.
This research identifies current trends in Digital Marketing utilization during the product lifecycle. The study also contains insights on Digital team staffing, including current headcount benchmarks and anticipated future staffing levels. It also examines staffing across key Digital team activities.
This study provides segment perspectives on large, mid-cap and small companies as well as global vs. U.S.-only companies.
Best Practices, LLC engaged 48 Digital Marketing leaders at 42 companies through a benchmarking survey instrument. Representatives from 8 companies participated in deep-dive interviews.
Pharmaceutical; Marketing; Diagnostic; Health Care; Consumer Products; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Medical Device; Science
Teva Pharmaceutical Industries Ltd; Triplefin; Chiesi; biokit; Abbott; Precision Therapeutics; Abbvie; Meridian Bioscience; Merck; Vivus; Bayer Healthcare; MD Outlook; Sanofi; Pfizer; Takeda Pharmaceuticals; Roche; Boehringer Ingelheim; GlaxoSmithKline ; Amgen; Novo Nordisk; Covidien; LEO Pharma; Biogen Idec; Olympus Corporation; Eisai; Mylan; UCB Pharma; Ferring Pharmaceuticals; Lundbeck; Catalent Pharma Solutions; Astellas; CSL Behring; Ranbaxy; Galderma; Boston Scientific; Edward Lifesciences; Purdue Pharma; Nektar Therapeutics; Merial; Genomic Health; Cochlear; Haemonetics Corporation
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.